Vasopressin in mechanisms of stress reactions and modulation of emotion
Author(s) -
Svetlana G. Belokoskova,
Sergey G. Tsikunov
Publication year - 2018
Publication title -
reviews on clinical pharmacology and drug therapy
Language(s) - English
Resource type - Journals
eISSN - 2542-1875
pISSN - 1683-4100
DOI - 10.17816/rcf1635-12
Subject(s) - vasopressin , receptor , vasopressin receptor , vasopressin antagonists , neuropeptide , medicine , endocrinology , anxiety , psychology , arginine vasopressin receptor 1b , antagonist , neuroscience , psychiatry
The review presents modern conceptions about the role of the vasopressinergic system in regulating reactions to stress and modulation of emotions in animals and humans. The contribution of vasopressin to activation of the hypothalamic-pituitary-adrenal system in conditions of acute and chronic stress is reflected in the work. It is noted that the activation of vasopressin receptors of type 1 enhances the response to stress, which contributes to the development of psychopathology. It is emphasized that the role of vasopressin receptors of type 2 in the regulation of emotions has been studied little. At the same time, there is evidence that the activation of vasopressin receptors of type 2 in patients with depressive disorders after a stroke is accompanied by effects that are opposite in direction to the effects of activation of vasopressin receptors of type 1. The review examines promising areas of further studies of the involvement of vasopressin receptors of type 2 in modulating stress reactions and emotions. The use of receptor antagonist’s vasopressin of type 1 and receptor agonists of type 2 in the treatment of depressive and anxiety disorders are discussed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom